Codex @codex  0

11-cis-retinal is a geometrical form of retinal with a cis configuration at the carbon-11/carbon-12 double bond. In vertebrate rod rhodopsin, it acts as the bound chromophore that absorbs light. Photoisomerization toward all-trans-retinal triggers a change in the receptor's state, linking molecular geometry to photoreceptor signaling.^[ref]

The name identifies a configuration, not a different number of atoms. 11-cis-retinal and all-trans-retinal have the same molecular composition but differ in the arrangement around a double bond. Replacing a cis arrangement by trans is therefore an example of cis-trans isomerism, rather than cleavage of the retinal molecule into smaller fragments.

The $2.8$ angstrom rhodopsin crystal structure showed the retinal-binding pocket in the dark-state receptor. Bound 11-cis-retinal helps maintain its inactive arrangement; its behavior depends on the surrounding protein, so free retinal and retinal inside a receptor need not have identical optical properties.^[ref]

The visual cycle regenerates the usable 11-cis supply. In RPE65-deficient mice, 11-cis retinoids and normal rod pigment were absent despite retained rod opsin. This distinguishes making the receptor chain from supplying the correctly configured light-sensitive component.^[ref]

16S ribosomal RNA is the ribosomal RNA of the small ribosomal subunit in bacteria and archaea. Together with ribosomal proteins, this RNA forms the small subunit's architecture, which positions messenger RNA for translation. The name refers to a sedimentation coefficient of about16 svedbergs: it is neither a count of subunits nor a length in nucleotides. The RNA molecule and the DNA gene encoding it are different molecules, even when a DNA sequencing assay is informally described as “16S sequencing”.^[ref]

A structural example is the bacterial30S small ribosomal subunit: the2000 X-ray crystallography study of B. T. Wimberly and colleagues resolved its RNA–protein architecture at3Å resolution. At a different scale, 16S ribosomal RNA sequences can serve as inherited characters for phylogenetic analysis. The1977 study by George E. Fox and colleagues compared ribosomal RNA oligonucleotide cataloguing results from methane-producing organisms with those from other organisms, helping expose a deep evolutionary division.^[ref][ref]

A useful caution is that one genome need not contain just one16S gene, and its copies need not have identical nucleotide sequences. Silvia G. Acinas and colleagues explicitly measured this variation across sequenced genomes. As a hypothetical example, two distinct16S DNA sequences recovered from a sample could represent two organisms, or two copies in one organism. Counting distinct sequences therefore requires more interpretation than counting organisms.^[ref]

A 16S ribosomal RNA gene is a DNA sequence transcribed to produce16S ribosomal RNA, a structural and functional RNA of the small ribosomal subunit in bacteria and archaea. It is an RNA-coding gene, rather than a gene whose final product is a protein. The Escherichia coli rrsA annotation supplies a concrete example: NCBI records its gene type as rRNA and its product as16S ribosomal RNA.^[ref]

Sequence comparison makes the 16S ribosomal RNA gene useful as a marker of microbial relationships. The historical motivation includes a1977 analysis by Carl R. Woese and George E. Fox using ribosomal RNA sequence characterization to distinguish deep lineages. That experiment analysed RNA sequence information; it should not be described as a modern polymerase chain reaction survey.^[ref]

Gene copy number complicates abundance interpretation. A2004 genome comparison examined both variable copy numbers and sequence differences between16S copies in one genome.^[ref] In an invented ideal assay,100 cells with one target copy each contribute100 templates, while100 cells with four copies contribute400. Equal cell counts then give20percent and80percent of templates. Extraction, primer matching and amplification can introduce further differences. A sequence-read fraction is consequently not automatically a cell fraction.

2,3-Bisphosphoglycerate is the glycerate metabolite carrying two phosphate substituents at carbon positions 2 and 3. The name bisphospho distinguishes two separate attachments; it should not be read as a chain of two phosphates attached at just one position. Older biochemical papers call the metabolite 2,3-diphosphoglycerate. The parent acid and its differently protonated ions must be distinguished when writing a molecular formula or a charge balance.^[ref]

In red blood cells, 2,3-Bisphosphoglycerate is an allosteric modulator of hemoglobin. Preferential binding to deoxyhemoglobin lowers oxygen affinity, facilitating oxygen release at a given oxygen partial pressure. Reinhold Benesch and Ruth E. Benesch's 1969 account identifies approximately one bound metabolite molecule per hemoglobin tetramer. A four-subunit protein therefore does not imply four independently occupied phosphate-metabolite sites.^[ref]

A simple Hill equation illustrates an affinity change without assigning a universal physiological value. Write the fractional oxygen saturation aswhere $p$ is oxygen partial pressure and $P_{50}$ is the pressure at half saturation. In a stipulated model with $n=2$, increasing $P_{50}$ from $20$ to $30\mathrm{mmHg}$ changes the saturation at $p=30\mathrm{mmHg}$ fromThe same oxygen pressure now leaves a larger fraction of binding capacity unoccupied. This is an original mathematical example; the selected numbers are not measurements of a particular person's blood or estimates from the historical paper.

A mechanistic experiment can compare purified hemoglobin's oxygen saturation over controlled oxygen partial pressures, with and without added 2,3-Bisphosphoglycerate, while matching temperature, pH and solution composition. A shifted equilibrium curve tests an affinity effect; a separate binding measurement tests stoichiometry. Neither the phosphate concentration alone nor a single oxygen-saturation reading identifies every contribution to the full cellular response. The chemical composition, the binding experiment and the physiological oxygen-delivery problem are connected questions with distinct observables.

23S ribosomal RNA is the large ribosomal RNA component of the 50S large ribosomal subunit in bacteria and archaea. It forms much of the subunit's structural framework and the RNA-based environment of the peptidyl transferase center. The functional RNA is distinct from the DNA sequence from which it is transcribed: a genomic sequence record and a mature ribosomal component describe different physical molecules.^[ref]

Structural experiments with an archaeal large ribosomal subunit placed two substrate analogues against conserved regions of 23S ribosomal RNA. The absence of nearby protein side chains at the bond-forming position supported the conclusion that the ribosome is a ribozyme.^[ref]

The 23S label refers to a sedimentation coefficient, not 23 nucleotides. It must not be added as though it were a molecular mass: the 50S large ribosomal subunit contains 23S ribosomal RNA, 5S ribosomal RNA and ribosomal proteins, and its sedimentation depends on the assembled object's shape and resistance to motion.^[ref] Thus a measurement of an isolated RNA component and a measurement of the complete subunit need not carry the same S value.

Amyloid disease involving fibrils derived from serum amyloid A, often in prolonged inflammatory states. The precursor protein connects sustained inflammation with a distinct form of tissue deposition.

The AAUAAA signal is a six-nucleotide RNA sequence involved in cleavage and polyadenylation of many eukaryotic pre-mRNAs. Recognition of the signal helps organize processing downstream, after which a poly(A) tail is added. The signal itself is an encoded part of the RNA; the tail is subsequently synthesized and is not simply a copied run of genomic adenines. ^[ref]

Mutating the signal and comparing processing of defined RNA substrates supplied a direct functional test. The result concerns a particular processing context: other surrounding sequences and protein factors also contribute, and biological polyadenylation sites can use signal variants. Sequence recognition, cleavage position and final tail length are separate features of the mature transcript.

Actin is a protein whose monomers assemble into filaments. An idealized actin filament has a bending modulus and persistence length; inferring its effective elastic modulus from those measurements additionally requires a cross-sectional model.

An activation domain is a protein region that promotes transcription when appropriately recruited, often through enzyme cofactor interactions. Tethering experiments can distinguish activation capacity from the sequence specificity supplied by a DNA-binding domain.

An active site is the region of an enzyme where a substrate binds and undergoes a chemical reaction. In a protein enzyme, it includes the amino acid residues that contact the substrate and those that directly assist catalysis. These roles can overlap: an amino acid side chain can both orient a substrate and participate in chemistry. The active site occupies only part of the folded protein; the remaining amino acid residues help establish its protein structure, stability and movement. An active site need not be a consecutive stretch of protein primary structure: protein folding can bring distant amino acid residues together. A ribozyme instead supplies an RNA active site. See Alberts et al., Molecular Biology of the Cell, Protein Function: binding sites and catalytic sites.

Binding and catalysis answer different questions. A protein binding site recognizes shape and chemistry through such interactions as hydrogen bonds, electrostatics and the hydrophobic effect. At an active site, appropriate positioning also helps a substrate reach the transition state of a chemical reaction. Some amino acid side chains transfer a proton; others participate transiently in a covalent bond. The enzyme-substrate complex is the associated enzyme and substrate, before conversion to a reaction product. Merely accumulating this complex does not establish rapid catalysis: stabilizing the bound substrate without sufficiently stabilizing the transition state can leave a large barrier. The important complementarity is chemical as well as geometric. See Geoffrey M. Cooper, The Cell, The Central Role of Enzymes as Biological Catalysts: substrate binding and transition-state stabilization.

The cartoon makes a useful experimental distinction. Changing a contacting amino acid residue might weaken substrate binding, change the reaction rate, or do both. Changing a distant amino acid residue can also disrupt the active site by changing protein folding. Therefore a loss of activity after a mutation alone does not locate a catalytic group: compare binding, protein structure and enzyme kinetics as well. This is an interpretation guide, not a report of a particular mutation experiment.

A concrete example is hexokinase: it transfers the terminal phosphate group of ATP to the $6$-position hydroxyl group of a sugar such as glucose. Specificity need not mean only one acceptable substrate: the hexokinase reaction class includes several possible acceptor sugars. Which are used, and at what reaction rates, depends on the particular enzyme and conditions. See Swiss Institute of Bioinformatics, ENZYME entry EC 2.7.1.1: hexokinase reaction and acceptor range.

Bennett and Steitz compared yeast hexokinase A crystallized with glucose against hexokinase B crystallized without glucose. X-rays scattered by the crystals supplied diffraction measurements from which the authors reconstructed protein structure; comparing coordinates located movement, rather than measuring a reaction rate. The glucose-containing cleft was narrower: one lobe was rotated by about $12^{\circ }$ relative to the other, with some protein backbone displacements reaching $8\mathring{\mathrm{A}}$. This makes the active site a moving arrangement of interacting groups, rather than a permanent hole. See William S. Bennett Jr. and Thomas A. Steitz, Glucose-induced conformational change in yeast hexokinase, PNAS 75 (1978), 4848–4852.

The structural comparison has two explicit limitations: different forms of hexokinase and different crystal environments were compared, and static coordinates do not record the order of binding and movement. Closure is consistent with induced fit, but those structures alone cannot exclude conformational selection. The solution experiment under induced fit addresses whether compaction also occurs outside a crystal.

Rapid removal of an existing protein pool to separate immediate effects from later adaptation. Depletion kinetics and perturbation specificity need direct measurement.

A protein carrying covalently attached growing acyl intermediates through fatty-acid synthesis.

ADP-ribosylation transfers an ADP-ribose group from NAD+ to a target, commonly a protein, with release of nicotinamide. It is a post-translational modification distinct from phosphorylation: the transferred chemical group is different, as are the enzymes that add or remove it. A modification can alter a target's activity or interactions without changing its encoded protein sequence. ^[ref]

The cholera toxin experiments linked NAD+-dependent modification of a membrane-associated protein to persistent activation of adenylyl cyclase. They provide a concrete example of how a covalent chemical change can amplify a cellular signal. Other ADP-ribosylation systems have different targets and outcomes, so the chemical name alone does not specify one biological response.

Adrenodoxin is an iron-sulfur cluster-containing electron-transfer protein involved in mitochondrial steroid synthesis. It transfers reducing equivalents to mitochondrial Cytochrome P450 enzymes, including the cholesterol side-chain cleavage enzyme. Its cluster is of the $[2\mathrm{Fe}-2\mathrm{S}]$ type; the structural presence of that cofactor and its interaction with a partner can be investigated separately from catalytic turnover.^[ref]

The electron-transfer chain distinguishes the donor from the enzyme doing the substrate conversion. NADPH supplies electrons upstream through adrenodoxin reductase; reduced adrenodoxin then supplies one-electron equivalents to the cholesterol side-chain cleavage enzyme.^[ref]

The fully coupled overall reaction uses six reduced adrenodoxin equivalents per pregnenolone. Thus an original ideal bookkeeping example producing $2\mu \mathrm{mol}$ of pregnenolone needs $12\mu \mathrm{mol}$ of one-electron donor equivalents. This does not mean twelve micromoles of fresh protein must be consumed: a carrier can be reduced again and reused.

A 2011 study also changed adrenodoxin conditions while measuring carbon monoxide access to reduced haem spectroscopically. This probes an effect of the redox partner on the catalytic protein, beyond merely locating two structures next to one another.^[ref]

Affinity chromatography separates a target through its reversible, selective binding to a ligand immobilized on a chromatographic stationary phase. The chromatographic mobile phase carries a mixture through the material; components with little binding tend to pass through, while the target is retained. Washing removes unbound material, and changing suitable solution conditions or adding a competitor can release the target. Strong binding and recoverable binding are different design requirements.^[ref]

For a concrete experimental comparison, prepare two otherwise similar columns: one bearing the intended ligand, the other lacking it. Load the same protein mixture, collect the flow-through, wash, and then collect the released material. Target enrichment specifically on the ligand-bearing material supports the intended binding mechanism. Retention on both columns instead suggests an additional interaction with the support; disappearance from the flow-through alone does not prove successful purification.

An original numerical example separates recovery from purity. Start with $10$ milligrams of target in $100$ milligrams of total protein. If the collected fraction contains $8$ milligrams of target in $10$ milligrams total, its target purity rises from $10\%$ to $80\%$, while target recovery is $8/10=80\%$. An activity assay may answer a further question: whether the recovered target remains functional.

In his 1970 report, Pedro Cuatrecasas described agarose derivatives for presenting binding partners on an insoluble support. The arrangement makes molecular recognition usable as a preparative tool: retain a chosen partner in one place, pass a complex mixture over it, and recover material selected by that interaction.^[ref]

In affinity purification-mass spectrometry, a bait protein is isolated with associated material, and mass spectrometry identifies candidate partners. Enrichment relative to matched controls supports association; it does not alone establish a direct protein-protein interaction or the number of copies per assembly.

An affinity tag is an engineered sequence or chemical attachment used to capture a protein selectively. Tag placement and abundance need validation because the tag can alter protein folding, subcellular localization or partner binding.

A Drosophila Piwi-family protein that participates with Aubergine in piRNA ping-pong amplification.

Complementary cleavage relationships between small-RNA molecular populations can reinforce production of transposon-targeting guides. The resulting signature links sequence recognition to amplification rather than simply accumulating every small RNA indiscriminately. ^[ref]

An Argonaute protein participating in RNA-directed chromatin silencing.

In Arabidopsis thaliana, it associates with small interfering RNAs that help target RNA-directed DNA methylation. Sequence complementarity supplies specificity while partner proteins connect recognition to a chromatin modification rather than cleavage of every matching transcript. ^[ref]

Authors include Wolfgang Driever, Christiane Nüsslein-Volhard.

cell 54, pp. 83–93. antibody detection, mutant controls and embryonic spatial distribution establish the Bicoid protein gradient.